* Evolent Health Inc EVH.N reported quarterly adjusted
earnings
of 14 cents per share for the quarter ended in June. The mean
expectation of ten analysts for the quarter was for earnings of
11 cents per share.
* Revenue rose 46.6% to $469.14 million from a year ago;
analysts
expected $460.70 million.
* Evolent Health Inc's reported EPS for the quarter was a
loss
of 37 cents.
* The mean earnings estimate of analysts had fallen by
about 13.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Evolent Health Inc shares had risen by 0.3% this
quarter and
gained 8.3% so far this year.
* The company reported a quarterly loss of $41.41 million.
* Wall Street's median 12-month price target for Evolent
Health
Inc is $46.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 2 at 10:32 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.11 0.14 Beat
Mar. 31 2023 0.20 0.21 Beat
Dec. 31 2022 0.16 0.10 Missed
Sep. 30 2022 0.12 0.59 Beat